Current report
Open the filing on sec.gov
BioRestorative Therapies, Inc. (BRTX)
Nasdaq: BRTX · Services-Misc Health & Allied Services, NEC · Melville, NY · filing with the SEC since 2010
The companyfiscal 2025, as filed
Revenue$359,700-10.3%
Net income-$14.2M-58.6%
Earnings per share$-1.58-36.2%
Operating cash flow-$10.8M-31.1%
Cash$1.5M+175.8%
Debtn/a
Shareholders’ equity$356,744-95.8%
Shares, diluted8,993,115+15.8%
Return on equity-3992.2%
The recordfrom its filings
Filings in 202640
Newest filingNov 12 · 8-K
Annual reportMar 26, 2026
Quarterly reportMay 14, 2026
Next report due10-Q by Aug 14 · overdue
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents granted7
Filer categoryNon-accelerated filer<br>Smaller reporting company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Current report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Current report, amended
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Late quarterly report notice
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Large holder update, amended
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.